Synthesis and Pharmacological Evaluation of Novel 1-(1,4-Alkylaryldisubstituted-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
Open Access
Abstract
Novel 1-(1,4-alkylaryldisubstituted-4,5-dihydro-1H-imidazo)-3-substituted urea derivatives have been synthesized and evaluated for their central nervous system activity. Compounds 3a–m were prepared in the reaction between the respective 1-alkyl-4-aryl-4,5-dihydro-1H-imidazol-2-amines 1a–c and appropriate isocyanates 2 in dichloromethane. The compounds were subjected to in silico ADMET studies in order to select best candidates for in vivo experiments. The effects of the compounds on the spontaneous locomotor activity and amphetamine-evoked hyperactivity were estimated. Analgesic activity, without or in the presence of naloxone, was assessed in the writhing test. The tendency to change the HTR, evoked by l-5-HTP and the involvement in alteration in body temperature in mice was studied. Additionally, to check possible occurrence of drug-induced changes in the muscle relaxant activity of mice, which may have contributed to their behaviour in other tests, the rota-rod and chimney tests were performed. The new urea derivatives exerted significant activities in the performed pharmacological tests, although the presented results show a preliminary estimation, and thus, need to be extended for identification and understanding the complete pharmacological profile of the examined compounds.Keywords
Funding Information
- European Commission (‘‘The equipment of innovative laboratories doing research on new medicines used in the therapy of civilization and neoplastic diseases’’)
- Intercollegiate Center for Management Science (G30-18)
- China Steel Corporation (not applicable)
This publication has 44 references indexed in Scilit:
- Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-ureaEuropean Journal of Medicinal Chemistry, 2009
- Antinociceptive activity of new imidazolidine carbonyl derivatives.European Journal of Medicinal Chemistry, 2005
- Recent advances in selective opioid receptor agonists and antagonistsMedicinal Research Reviews, 2003
- Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidineEuropean Journal of Medicinal Chemistry, 2002
- Dopamine receptors: Molecular biology, biochemistry and behavioural aspectsPharmacology & Therapeutics, 1994
- Do functional relationships exist between 5-HT1A and 5-HT2 receptors?Pharmacology Biochemistry and Behavior, 1990
- Central noradrenaline depletion attenuates amphetamine-induced locomotor behaviorNeuroscience Letters, 1986
- Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamineBehavioral and Neural Biology, 1985
- The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonistNeuropharmacology, 1983
- Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperoneNeuropharmacology, 1983